Clinical Pharmacokinetics and Pharmacodynamics of Celecoxib
Top Cited Papers
- 1 March 2000
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 38 (3), 225-242
- https://doi.org/10.2165/00003088-200038030-00003
Abstract
Celecoxib, a nonsteroidal anti-inflammatory drug (NSAID), is the first specific inhibitor of cyclo-oxygenase-2 (COX-2) approved to treat patients with rheumatism and osteoarthritis. Preliminary data...Keywords
This publication has 54 references indexed in Scilit:
- Expression and localization of cyclo-oxygenase isoforms in non-small cell lung cancerEuropean Respiratory Journal, 1999
- Expression and localization of cyclo-oxygenase isoforms in non-small cell lung cancerEuropean Respiratory Journal, 1999
- Increased Expression of Cyclooxygenases and Peroxisome Proliferator-Activated Receptor-γ in Alzheimer's Disease BrainsBiochemical and Biophysical Research Communications, 1999
- The advent of highly selective inhibitors of cyclooxygenase—a reviewProstaglandins & Other Lipid Mediators, 1998
- Effects of inhibitors of the activity of cyclo‐oxygenase‐2 on the hypotension and multiple organ dysfunction caused by endotoxin: A comparison with dexamethasoneBritish Journal of Pharmacology, 1998
- CYCLOOXYGENASES 1 AND 2Annual Review of Pharmacology and Toxicology, 1998
- Topical NSAIDs for Musculoskeletal ConditionsDrugs, 1998
- Nonsteroidal antiinflammatory drugs in rheumatoid arthritis and osteoarthritis. Support for the concept of “responders” and “nonresponders”Arthritis & Rheumatism, 1997
- Nonsteroidal antiinflammatory drugs and uncoupling of mitochondrial oxidative phosphorylationArthritis & Rheumatism, 1996
- Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase IINature, 1995